Пожалуйста, используйте этот идентификатор, чтобы цитировать или ссылаться на этот ресурс: http://elar.urfu.ru/handle/10995/90204
Полная запись метаданных
Поле DCЗначениеЯзык
dc.contributor.authorVeniaminova, E.en
dc.contributor.authorCespuglio, R.en
dc.contributor.authorChernukha, I.en
dc.contributor.authorSchmitt-Boehrer, A. G.en
dc.contributor.authorMorozov, S.en
dc.contributor.authorKalueff, A. V.en
dc.contributor.authorKuznetsova, O.en
dc.contributor.authorAnthony, D. C.en
dc.contributor.authorLesch, K. -P.en
dc.contributor.authorStrekalova, T.en
dc.date.accessioned2020-09-29T09:46:24Z-
dc.date.available2020-09-29T09:46:24Z-
dc.date.issued2020-
dc.identifier.citationMetabolic, Molecular, and Behavioral Effects of Western Diet in Serotonin Transporter-Deficient Mice: Rescue by Heterozygosity? / E. Veniaminova, R. Cespuglio, I. Chernukha, A. G. Schmitt-Boehrer, et al. . — DOI 10.3389/fnins.2020.00024 // Frontiers in Neuroscience. — 2020. — Iss. 14. — 24.en
dc.identifier.issn1662-4548-
dc.identifier.otherhttps://www.frontiersin.org/articles/10.3389/fnins.2020.00024/pdfpdf
dc.identifier.other1good_DOI
dc.identifier.othercd86d679-89e9-4aaf-8249-62427ea44f36pure_uuid
dc.identifier.otherhttp://www.scopus.com/inward/record.url?partnerID=8YFLogxK&scp=85081241991m
dc.identifier.urihttp://elar.urfu.ru/handle/10995/90204-
dc.description.abstractReduced function of the serotonin transporter (SERT) is associated with increased susceptibility to anxiety and depression and with type-2 diabetes, which is especially true in older women. Preference for a “Western diet” (WD), enriched with saturated fat, cholesterol, and sugars, may aggravate these conditions. In previous studies, decreased glucose tolerance, central and peripheral inflammation, dyslipidemia, emotional, cognitive, and social abnormalities were reported in WD-fed young female mice. We investigated the metabolic, molecular, and behavioral changes associated with a 3-week-long dietary regime of either the WD or control diet in 12-month-old female mice with three different Sert genotypes: homozygous (Slc6a4) gene knockout (Sert−/−: KO), heterozygous (Sert+/−: HET), or wild-type mice (Sert+/+: WT). In the WT-WD and KO-WD groups, but not in HET-WD-fed mice, most of changes induced by the WD paralleled those found in the younger mice, including brain overexpression of inflammatory marker Toll-like receptor 4 (Tlr4) and impaired hippocampus-dependent performance in the marble test. However, the 12-month-old female mice became obese. Control diet KO mice exhibited impaired hippocampal-dependent behaviors, increased brain expression of the serotonin receptors Htr2c and Htr1b, as well as increased Tlr4 and mitochondrial regulator, peroxisome proliferator-activated receptor gamma-coactivator-1a (Ppargc1a). Paradoxically, these, and other changes, were reversed in KO-WD mutants, suggesting a complex interplay between Sert deficiency and metabolic factors as well as potential compensatory molecular mechanisms that might be disrupted by the WD exposure. Most, but not all, of the changes in gene expression in the brain and liver of KO mice were not exhibited by the HET mice fed with either diet. Some of the WD-induced changes were similar in the KO-WD and HET-WD-fed mice, but the latter displayed a “rescued” phenotype in terms of diet-induced abnormalities in glucose tolerance, neuroinflammation, and hippocampus-dependent performance. Thus, complete versus partial Sert inactivation in aged mice results in distinct metabolic, molecular, and behavioral consequences in response to the WD. Our findings show that Sert+/− mice are resilient to certain environmental challenges and support the concept of heterosis as evolutionary adaptive mechanism. © Copyright © 2020 Veniaminova, Cespuglio, Chernukha, Schmitt-Boehrer, Morozov, Kalueff, Kuznetsova, Anthony, Lesch and Strekalova.en
dc.description.sponsorship01EW1602B, 01EW1902, 602805en
dc.description.sponsorshipDeutsche Forschungsgemeinschaft, DFG: CRC TRR 58 A1/A5en
dc.description.sponsorshipHorizon 2020 Framework Programme, H2020: Eat2beNICE, 728018, 643051en
dc.description.sponsorshipRussian Science Foundation, RSF: 16-16-10073en
dc.description.sponsorshipSeventh Framework Programme, FP7en
dc.description.sponsorshipI.M. Sechenov First Moscow State Medical University, MSMUen
dc.description.sponsorshipDeutsche Forschungsgemeinschaft, DFGen
dc.description.sponsorshipWe thank Collette Rousset and Donia Amrouni from C. Bernard University, Anna Gorlova from Sechenov University, and Anastasiya Kibitkina and Galina Tolmacheva from the Gorbatov Research Center for their valuable contribution to this work. Funding. The authors? work reported here was supported by the Deutsche Forschungsgemeinschaft (DFG: CRC TRR 58 A1/A5), the European Union?s Seventh Framework Programme (FP7/2007?2013) under Grant No. 602805 (Aggressotype), ERA-Net NEURON/RESPOND, No. 01EW1602B and ERA-Net NEURON/DECODE, No. 01EW1902 (to K-PL), the Horizon 2020 Research and Innovation Programme under Grant No. 728018 (Eat2beNICE) and Grant No. 643051 (MiND), 5-100 Russian Academic Excellence Project (to K-PL and TS), the Russian Science Foundation (RSF) Project No. 16-16-10073 (to IC and OK), and the University of W?rzburg in the funding programme Open Access Publishing (to KP-L).en
dc.format.mimetypeapplication/pdfen
dc.language.isoenen
dc.publisherFrontiers Media S.A.en
dc.relationinfo:eu-repo/grantAgreement/RSF//16-16-10073en
dc.rightsinfo:eu-repo/semantics/openAccessen
dc.rightscc-byother
dc.sourceFrontiers in Neuroscienceen
dc.subjectAGINGen
dc.subjectGLUCOSE TOLERANCEen
dc.subjectHETEROSISen
dc.subjectOBESITYen
dc.subjectSEROTONIN RECEPTORSen
dc.subjectSERT-DEFICIENT MICEen
dc.subjectTOLL-LIKE RECEPTOR 4 (TLR4)en
dc.subjectWESTERN DIETen
dc.subjectPEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHAen
dc.subjectSEROTONIN RECEPTORen
dc.subjectSEROTONIN RECEPTOR HTR1Aen
dc.subjectSEROTONIN RECEPTOR HTR1Ben
dc.subjectSEROTONIN RECEPTOR HTR2Aen
dc.subjectSEROTONIN RECEPTOR HTR2Cen
dc.subjectSEROTONIN TRANSPORTERen
dc.subjectTOLL LIKE RECEPTOR 4en
dc.subjectUNCLASSIFIED DRUGen
dc.subjectANIMAL BEHAVIORen
dc.subjectANIMAL EXPERIMENTen
dc.subjectARTICLEen
dc.subjectCONTROLLED STUDYen
dc.subjectEMOTIONALITYen
dc.subjectEVOLUTIONARY ADAPTATIONen
dc.subjectFEMALEen
dc.subjectGENEen
dc.subjectGENE KNOCKOUTen
dc.subjectGENE OVEREXPRESSIONen
dc.subjectGENOTYPEen
dc.subjectHETEROZYGOSITYen
dc.subjectHIPPOCAMPUSen
dc.subjectMETABOLIC PARAMETERSen
dc.subjectMOLECULAR BIOLOGYen
dc.subjectMOUSEen
dc.subjectNERVOUS SYSTEM INFLAMMATIONen
dc.subjectNONHUMANen
dc.subjectOBESITYen
dc.subjectPROTEIN EXPRESSIONen
dc.subjectSLC6A4 GENEen
dc.subjectUPREGULATIONen
dc.subjectWESTERN DIETen
dc.titleMetabolic, Molecular, and Behavioral Effects of Western Diet in Serotonin Transporter-Deficient Mice: Rescue by Heterozygosity?en
dc.typeArticleen
dc.typeinfo:eu-repo/semantics/articleen
dc.typeinfo:eu-repo/semantics/publishedVersionen
dc.identifier.doi10.3389/fnins.2020.00024-
dc.identifier.scopus85081241991-
local.affiliationDepartment of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlandsen
local.affiliationLaboratory of Psychiatric Neurobiology, Institute of Molecular Medicine, Sechenov First Moscow State Medical University, Moscow, Russian Federationen
local.affiliationFaculty of Medicine, Neuroscience Research Center of Lyon, C. Bernard University Lyon 1, Lyon, Franceen
local.affiliationV.M. Gorbatov Federal Research Center for Food Systems of RAS, Moscow, Russian Federationen
local.affiliationDivision of Molecular Psychiatry, Center of Mental Health, University of Würzburg, Würzburg, Germanyen
local.affiliationInstitute of General Pathology and Pathophysiology, Moscow, Russian Federationen
local.affiliationSchool of Pharmacy, Southwest University, Chongqing, Chinaen
local.affiliationInstitute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, Russian Federationen
local.affiliationUral Federal University, Ekaterinburg, Russian Federationen
local.affiliationDepartment of Pharmacology, Oxford University, Oxford, United Kingdomen
local.contributor.employeeVeniaminova, E., Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands, Laboratory of Psychiatric Neurobiology, Institute of Molecular Medicine, Sechenov First Moscow State Medical University, Moscow, Russian Federationru
local.contributor.employeeCespuglio, R., Laboratory of Psychiatric Neurobiology, Institute of Molecular Medicine, Sechenov First Moscow State Medical University, Moscow, Russian Federation, Faculty of Medicine, Neuroscience Research Center of Lyon, C. Bernard University Lyon 1, Lyon, Franceru
local.contributor.employeeChernukha, I., V.M. Gorbatov Federal Research Center for Food Systems of RAS, Moscow, Russian Federationru
local.contributor.employeeSchmitt-Boehrer, A.G., Division of Molecular Psychiatry, Center of Mental Health, University of Würzburg, Würzburg, Germanyru
local.contributor.employeeMorozov, S., Institute of General Pathology and Pathophysiology, Moscow, Russian Federationru
local.contributor.employeeKalueff, A.V., School of Pharmacy, Southwest University, Chongqing, China, Institute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, Russian Federation, Ural Federal University, Ekaterinburg, Russian Federationru
local.contributor.employeeKuznetsova, O., V.M. Gorbatov Federal Research Center for Food Systems of RAS, Moscow, Russian Federationru
local.contributor.employeeAnthony, D.C., Laboratory of Psychiatric Neurobiology, Institute of Molecular Medicine, Sechenov First Moscow State Medical University, Moscow, Russian Federation, Department of Pharmacology, Oxford University, Oxford, United Kingdomru
local.contributor.employeeLesch, K.-P., Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands, Laboratory of Psychiatric Neurobiology, Institute of Molecular Medicine, Sechenov First Moscow State Medical University, Moscow, Russian Federation, Division of Molecular Psychiatry, Center of Mental Health, University of Würzburg, Würzburg, Germanyru
local.contributor.employeeStrekalova, T., Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands, Laboratory of Psychiatric Neurobiology, Institute of Molecular Medicine, Sechenov First Moscow State Medical University, Moscow, Russian Federation, Division of Molecular Psychiatry, Center of Mental Health, University of Würzburg, Würzburg, Germany, Institute of General Pathology and Pathophysiology, Moscow, Russian Federationru
local.issue14-
dc.identifier.wos000518936300001-
local.identifier.pure12436139-
local.description.order24-
local.identifier.eid2-s2.0-85081241991-
local.fund.rsf16-16-10073-
local.identifier.wosWOS:000518936300001-
Располагается в коллекциях:Научные публикации ученых УрФУ, проиндексированные в SCOPUS и WoS CC

Файлы этого ресурса:
Файл Описание РазмерФормат 
10.3389-fnins.2020.00024.pdf2,71 MBAdobe PDFПросмотреть/Открыть


Все ресурсы в архиве электронных ресурсов защищены авторским правом, все права сохранены.